https://www.selleckchem.com/products/wz-811.html
ure which could accurately predict the prognosis of KIRC patients. We constructed an m6A-related lncRNAs prognostic signature which could accurately predict the prognosis of KIRC patients. This study aims to investigate the value of contrast-enhanced ultrasound (CEUS) in the differential diagnosis and risk stratification of ACR TI-RADS category 4 and 5 thyroid nodules with non-hypovascular. From January 2016 to December 2019 in our hospital, 217 ACR TI-RADS category 4and 5 nodules with non-hypovascular in 210 consecutive patients were in
Beğen
Yorum Yap
Paylaş
